Edna F Davis, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2007 Oak Tree Cove, Suite 201, Hernando, MS 38632 Phone: 662-429-8802 Fax: 662-429-8698 |
Dr. Lorenzo C Cabe, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 900 E Commerce St, Hernando, MS 38632 Phone: 662-429-9111 Fax: 662-429-6111 |
Dr. Robert Rhodes Meacham Iii, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 124 W Commerce St, Hernando, MS 38632 Phone: 662-429-5221 Fax: 662-429-7917 |
Yashwant M Chowdhary, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 900 E Commerce St, Hernando, MS 38632 Phone: 662-429-9111 Fax: 662-429-6111 |
Dr. Sushma Chowdhary, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 900 E Commerce St, Hernando, MS 38632 Phone: 662-429-9111 Fax: 662-429-6111 |
News Archive
Health and wellness technology leader BettrLife, and pioneer in consumer connected health devices Withings, have announced a business partnership to jointly promote their interactive mobile healthcare applications and products.
Scientists from Staffordshire University claim that new 3D printed insoles can significantly improve the foot health of people suffering with diabetes.
ISTA Pharmaceuticals, Inc., today announced the Company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery.
Organically farmed food has a bigger climate impact than conventionally farmed food, due to the greater areas of land required. This is the finding of a new international study involving Chalmers University of Technology, Sweden, published in the journal Nature.
Pfizer Inc. announced today that it has completed the sale of its Nutrition business to Nestlé for $11.85 billion in cash, following the conclusion of the required regulatory process in most markets. In certain countries where completion will be delayed due to ongoing regulatory review, Pfizer will continue to operate the business on an interim basis.
› Verified 9 days ago